303999
Filling the gap in elder abuse: A Medical Legal Partnership
AIMS: Identify the gaps in a CCR process experiencing increased elder abuse reports and review the advantages and disadvantages of a medical-legal partnership program as a reliable response to increasing positive outcomes in elder abuse cases.
RESULTS: In 2014, an educational grant became the focus of the local consortium with funding to explore a medical-legal partnership prevention program. While the community focused on education, talks between health care and legal providers are working toward medical legal partnerships to solve the gaps in health and legal services, which will lead to long-term, sustainable, and more effective solutions for victimized elders.
DISCUSSION: Medical-legal partnership is a care delivery model improving health in vulnerable populations by addressing unmet legal needs and removing legal barriers that impede health. The assumption is that the establishment of a medical-legal partnership will benefit elder abuse victims in the mid-south. To that end, legal professionals from private sector pro bono communities and healthcare teams are actively collaborating to establish direct legal assistance in healthcare institutions to elder abuse victims to ensure a safe recovery.
Learning Areas:
Ethics, professional and legal requirementsProgram planning
Learning Objectives:
Identify the gaps in a CCR process experiencing increased elder abuse reports and explain the advantages and disadvantages of a medical-legal partnership program as a valid response to increasing reports of elder abuse.
Keyword(s): Violence & Injury Prevention, Community-Based Partnership & Collaboration
Qualified on the content I am responsible for because: I have been principle of federally funded grants focusing on public health workforce development, formative and summative program evaluations with local, national and international safety net organizations.
Any relevant financial relationships? No
I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.